Trellis Bioscience LLC
http://www.trellisbio.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Trellis Bioscience LLC
MedImmune licenses antibodies from Trellis
MedImmune has acquired the worldwide rights to develop and commercialise Trellis Bioscience's antibodies that are directed against the respiratory syncytial virus (RSV).
Promedior and Stromedix Spot Fresh Approaches in Fibrosis
New approaches to treating fibrotic disorders have led to start-up financing for Promedior and Stromedix, two biotechs with early-stage in-licensed large molecule programs. To succeed where others have so-far failed the two newcomers will need innovative clinical strategies to accelerate their paths to proof-of-concept.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Trellis Bioscience LLC
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice